CONDITION

Mammary Adenocarcinoma in Cats

Mammary adenocarcinoma is a malignant tumour that arises from the glandular tissue of the mammary glands. In cats, these tumours tend to behave more aggressively than similar growths in dogs, and they can spread to other parts of the body, including the lungs and lymph nodes. The tissue involved is the same tissue that produces milk, though these tumours can appear in neutered and intact females, and occasionally in males. Owners often first notice a lump or firm mass along the mammary chain—the paired rows of glands that run along the underside of the chest and abdomen. These lumps may grow quickly or slowly, may be single or multiple, and may feel fixed or mobile beneath the skin. Some cats show no other signs at first, whilst others may develop ulceration of the overlying skin, or changes in appetite, breathing, or energy if the disease has spread. This page explores the signals that may prompt an owner's attention, the biological processes that underlie mammary tumours in cats, the investigations used to characterise them, and the range of approaches that exist for managing this condition. The aim is to orient, not to advise, and to provide a framework for understanding what may be observed.

Why this matters now

Mammary adenocarcinoma in cats tends to appear in older animals, with the majority of cases occurring in cats over ten years of age. Siamese cats may develop these tumours at a younger age than other breeds. Intact females and those neutered later in life appear to carry higher risk, though the disease can occur in cats neutered early and, rarely, in males. The influence of reproductive hormones on mammary tissue over time is thought to contribute to this age and neutering pattern.

The course of mammary adenocarcinoma in cats is often measured in months rather than years, and the disease tends to progress more quickly than similar tumours in dogs. A lump may remain stable for a period before beginning to grow, or it may enlarge steadily from the time it is first noticed. Spread to regional lymph nodes and distant sites such as the lungs can occur early in the course of disease, and some cats will have microscopic metastatic disease at the time the primary tumour is discovered. The interval between detection and evidence of spread varies widely between individuals.

Signals & patterns

Early signals

Firm lump along the belly

An owner may feel a discrete nodule or mass beneath the skin, often during grooming or stroking. These lumps are usually firm, may be pea-sized or larger, and can appear anywhere along the paired mammary chains that run from the chest to the groin.

Multiple small nodules

Some cats develop more than one lump, either clustered within a single gland or scattered across several glands on one or both sides. Each nodule may feel slightly different in texture or mobility.

Rapid growth of a mass

A lump that was small or unnoticed a few weeks earlier may become noticeably larger within a short period. This change in size can be the feature that draws attention, particularly if the cat is handled regularly.

Redness over the lump

The skin overlying a mammary mass may appear pink or inflamed, even in the absence of obvious injury. This can reflect the biological activity within the tumour or early changes in the overlying tissue.

Later signals

Ulceration or discharge

As a tumour enlarges, the skin above it may break down, forming an open sore that may weep clear fluid, blood, or pus. This can occur when the growth outpaces the blood supply to the overlying skin.

Difficulty breathing

Increased respiratory rate or effort, particularly at rest, can signal that tumour cells have spread to the lungs. This may be accompanied by reduced willingness to move or a shift in how the cat positions itself.

Weight loss or reduced appetite

A cat with advanced disease may eat less or lose body condition, reflecting the metabolic demands of the tumour or the presence of disease in multiple organs. This change is often gradual and may be noticed over weeks.

Click to read about the biological mechanisms

How this is usually investigated

Investigation of a suspected mammary tumour in a cat typically begins with examination of the mass itself and palpation of regional lymph nodes, followed by imaging to assess the extent of disease within the chest and abdomen. Fine-needle aspiration or biopsy of the mass provides tissue for examination under the microscope, which can distinguish between benign and malignant changes and characterise the type of tumour present. Blood tests and imaging of the lungs help to assess the overall health of the animal and to identify whether the disease has spread to distant sites.

Physical examination and palpation

Purpose: The veterinary surgeon assesses the size, location, mobility, and texture of the mass, and palpates the regional lymph nodes for enlargement. This initial examination provides information about whether the tumour is fixed to underlying structures and whether lymph nodes draining the area are involved.
Considerations: Palpation alone cannot distinguish benign from malignant tissue, and small or deeply situated lymph node metastases may not be detectable by touch. The examination provides a baseline for monitoring change over time.

Fine-needle aspiration or tissue biopsy

Purpose: A sample of cells or tissue is taken from the mass and examined under the microscope to identify the cell type and degree of malignancy. This can confirm whether the tumour is a mammary adenocarcinoma and provide information about its grade, which reflects how abnormal the cells appear.
Considerations: Fine-needle aspiration is quicker and less invasive but may not always yield enough cells for a definitive diagnosis. Surgical biopsy provides more tissue but involves anaesthesia and a small procedure, and a complete excision may be performed at the same time.

Thoracic radiography

Purpose: Radiographs of the chest are used to identify masses or nodules in the lungs, which may indicate that the tumour has spread. The appearance and number of lesions, if present, inform the overall picture of disease extent.
Considerations: Very small metastatic lesions may not be visible on plain radiographs, and advanced imaging such as computed tomography can detect smaller changes. Not all cats with mammary adenocarcinoma will have visible lung involvement at the time of diagnosis.

Lymph node aspiration or biopsy

Purpose: If a lymph node is enlarged or feels abnormal, a sample may be taken to assess whether tumour cells are present. This helps to determine whether the disease has spread locally beyond the primary mass.
Considerations: Lymph nodes can enlarge due to reactive inflammation as well as tumour spread, and microscopic examination is needed to distinguish between the two. Normal-sized lymph nodes can still harbour small numbers of malignant cells that are not detected by routine sampling.

Blood biochemistry and haematology

Purpose: Blood tests assess kidney and liver function, blood cell counts, and overall metabolic status. These results help to identify concurrent disease and inform decisions about anaesthesia and treatment options.
Considerations: Blood tests do not diagnose mammary adenocarcinoma itself, but they provide context about the animal's general health and may reveal abnormalities that influence the approach to management. Some cats with advanced disease may have normal blood results.

Options & trade-offs

Management of mammary adenocarcinoma in cats is typically individualised, taking into account the extent of disease, the age and health of the animal, and the preferences and circumstances of the owner. Approaches often combine surgical removal of the tumour, monitoring for recurrence or spread, and supportive care to maintain quality of life. Different combinations of interventions suit different animals and households, and the course of disease varies widely between individuals.

Surgical excision

Removal of the tumour, often with a margin of surrounding tissue and sometimes with one or more entire mammary glands or chains, aims to eliminate the primary mass and reduce the burden of disease. Surgery may involve removal of a single gland, a chain of glands on one side, or both chains if multiple tumours are present. Regional lymph nodes may be removed at the same time if they appear involved.

Trade-offs: Surgery requires general anaesthesia, which carries risk in older cats or those with concurrent disease. Wide excision can result in large wounds that take time to heal, and surgery does not address microscopic spread that may already be present at distant sites. Some tumours recur locally after removal, and the procedure does not prevent new tumours from developing in remaining mammary tissue.

Chemotherapy

Systemic chemotherapy involves the administration of drugs that target rapidly dividing cells, with the aim of slowing the growth of metastatic disease or reducing the risk of spread after surgery. Protocols vary in the drugs used, the frequency of administration, and the duration of treatment. Chemotherapy is typically delivered intravenously at intervals over several weeks or months.

Trade-offs: Response to chemotherapy in feline mammary adenocarcinoma is variable, and many cats show limited or transient improvement. Side effects can include nausea, reduced appetite, and suppression of bone marrow function, though these are often mild and manageable. The approach involves repeated visits for administration and monitoring, which may be difficult for some cats or owners, and it does not cure the disease in most cases.

Monitoring and supportive care

Some owners choose to monitor the tumour over time, particularly if the cat is elderly, has significant concurrent disease, or if the tumour has already spread widely. Supportive care focuses on maintaining appetite, managing pain or discomfort, and preserving quality of life. Adjustments to the environment, feeding routine, or activity level may be made as the disease progresses.

Trade-offs: This approach does not slow tumour growth or prevent spread, and the disease will typically progress over time. It avoids the risks and stress of anaesthesia and repeated treatments, and it allows the owner to observe the animal's daily experience and adjust care in response. The time between diagnosis and significant decline varies, and some cats remain comfortable for weeks or months.

Pain management and palliative care

Medications to relieve pain and inflammation can be used alongside other treatments or as a standalone approach, particularly when the tumour becomes ulcerated or causes discomfort. Non-steroidal anti-inflammatory drugs, opioids, or other analgesics may be given, and adjustments are made based on the animal's response.

Trade-offs: Pain relief does not alter the course of the disease but can improve comfort and quality of life during the period the tumour is present. Some medications require regular monitoring for side effects, particularly in cats with kidney or liver disease. The need for pain management may increase over time as the tumour enlarges or spreads.

Common misconceptions

Misconception:

"A mammary lump in a neutered cat cannot be cancer because the reproductive organs have been removed."

Reality:

Neutering reduces the risk of mammary tumours, particularly when performed early in life, but it does not eliminate the possibility. Mammary tissue remains present after neutering and retains the capacity for malignant transformation, particularly in cats neutered later or those with prolonged exposure to reproductive hormones. Many cats diagnosed with mammary adenocarcinoma have been neutered for years.

Misconception:

"If the tumour is removed completely, the cancer will not come back."

Reality:

Surgical removal of the primary tumour can eliminate the visible mass, but it does not guarantee that the disease will not recur or spread. Microscopic tumour cells may already be present in lymph nodes or distant organs at the time of surgery, and new tumours can develop in remaining mammary tissue. Wide surgical margins and removal of regional lymph nodes reduce local recurrence, but they do not prevent metastatic disease.

Misconception:

"Chemotherapy will cure mammary cancer in cats."

Reality:

Chemotherapy in cats with mammary adenocarcinoma is used to slow disease progression or to reduce the burden of metastatic disease, but it rarely achieves a cure. Response rates vary, and many tumours show limited sensitivity to available drugs. The goal is often to extend the period of good quality life rather than to eliminate the cancer entirely.

Related conditions

Mammary Tumours in Dogs

Mammary tumours in dogs arise from the same glandular tissue and share many biological features with those in cats, though feline mammary adenocarcinoma tends to behave more aggressively and is more likely to be malignant at the time of diagnosis.

Lymphoma in Cats

Lymphoma in cats is another form of malignancy that can spread to multiple organs including the lungs and lymph nodes, and occasionally both conditions may be considered during the investigation of a cat with weight loss, lethargy, or signs of systemic illness.

Injection-Site Sarcoma in Cats

Injection-site sarcoma is another malignant tumour that occurs in cats and shares the tendency for local invasion and recurrence, though it arises from soft tissue at injection sites rather than from glandular mammary tissue.

Sebaceous Cysts

Sebaceous cysts can appear as lumps beneath the skin and may occasionally be confused with mammary masses during an owner's initial examination, though they are benign and arise from sebaceous glands rather than mammary tissue.

Lipomas

Lipomas are benign fatty lumps that can develop along the underside of the chest or abdomen in cats, and may sometimes be felt in locations similar to mammary tissue, though they are soft, slow-growing, and do not share the malignant behaviour of mammary adenocarcinoma.

Understanding how mammary adenocarcinoma tends to progress in cats can inform observations at home and conversations with the veterinary team about what might be seen over time. The relationship between reproductive hormones and mammary tissue is explored in other longevity-related content, as is the broader picture of cancer biology and the factors that influence prognosis. Tracking changes in the size or character of a mass, in breathing pattern, or in general demeanour provides information that shapes the approach to monitoring and care.